[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 18, 1953


Author Affiliations

New York
From the Department of Pharmacology of Cornell University Medical College, the Cardiovascular Research Unit of the Beth Israel Hospital, and the Cardiology Service of the Hospital for Joint Diseases.

JAMA. 1953;152(12):1130-1131. doi:10.1001/jama.1953.03690120046011

In the treatment of the patient with congestive failure, the experience of recent years has firmly established the fact that it is the major if not the first order of business to put to work an effective system of diuretic medication. The recognition of this fact has altered the therapeutic approach and results in the management of these patients. In a study published from our clinics a few years ago,1 it was shown that with the daily mercurial as the nucleus of the regimen for the routine treatment of congestive failure, approximately 90%, instead of the usual 50 to 60%, of hospital patients may be discharged free of congestive failure in an average of about a week, in place of about three or four weeks. One of the points of emphasis in the current planning for this group is that of adequate maintenance with the continued use of potent

First Page Preview View Large
First page PDF preview
First page PDF preview